India, July 15 -- Immuneel Therapeutics has entered into a strategic Memorandum of Understanding (MoU) with Tata Memorial Centre (TMC), an aided institute under the Department of Atomic Energy and India's leading comprehensive cancer treatment and research institutions, to accelerate clinical and translational research in advanced cell and gene therapies.

The collaboration marks a significant step toward strengthening India's innovation ecosystem in oncology and improving access to next-generation therapies for patients with difficult-to-treat cancers. Through this partnership, Immuneel and TMC aim to combine their respective expertise in clinical research, product development, manufacturing, and cancer care to drive meaningful advanceme...